Clinical Trial Simulation is a computational modeling technique that belongs to the class of in silico methods used in drug development, specifically distinguished by its purpose of prospectively simulating the design, execution, and outcomes of clinical trials to predict the probabilistic behavior of drug responses in virtual populations under controlled experimental conditions.
304
Publications
23.3K
Citations
1.4K
Authors
634
Institutions
Publications per year
2017–2026
124
Variants
In Silico Clinical Trials
Parents
Publications
304
1–5 of 304
Authors
1.4K
- MV
5
h-index
- OD
5
h-index
- JG
4
h-index
- AAAlexander A. Vinks
Cincinnati Children's Hospital Medical Center, United States
4 publications · 115 citations
4
h-index
- DD
4
h-index
1–5 of 1.4K
Institutions
634
Pfizer (United States)
New York, United States
13 h-index
35 publications
1.7K citations
Harvard University
Cambridge, United States
9 h-index
24 publications
1.5K citations
United States Food and Drug Administration
Silver Spring, United States
9 h-index
35 publications
1.2K citations
Eli Lilly (United States)
Indianapolis, United States
8 h-index
16 publications
731 citations
Inserm
Paris, France
8 h-index
19 publications
753 citations
Johns Hopkins University
Baltimore, United States
8 h-index
18 publications
867 citations
Medical University of Vienna
Vienna, Austria
8 h-index
17 publications
465 citations
The University of Texas Southwestern Medical Center
Dallas, United States
7 h-index
9 publications
524 citations
1–8 of 634
Venues
- CPT Pharmacometrics & Systems Pharmacology
PSP · 15 publications · 575 citations
12
h-index
- Clinical Pharmacology & Therapeutics
CPT · 9 publications · 575 citations
9
h-index
- Pharmaceutical Research
9 publications · 362 citations
9
h-index
- Pharmaceutical Statistics
8 publications · 186 citations
8
h-index
- Statistics in Medicine
8 publications · 250 citations
8
h-index
1–5